How much of Altria's $2 billion buyback authorization has been used as of June 30, 2026?

Altria has deployed $335 million of the $2 billion authorization through the first half of 2026, leaving $665 million remaining. The program expires on December 31, 2026. At the current burn rate (approximately $167.5 million per quarter based on H1 results), the remaining funds could support continued repurchases through year-end, though actual execution depends on market conditions and board discretion.

What was the average price paid per share in Q2 2026 versus the first-half average?

In Q2 2026, Altria paid an average of $65.11 per share, compared to the first-half average of $62.78 per share. The higher Q2 price reflects typical seasonal pricing in open-market buybacks and any price appreciation during the second quarter relative to Q1 2026.

How did the share repurchases affect Altria's per-share earnings growth?

The 5.3 million shares repurchased in H1 2026 reduced the weighted-average diluted share count from 1.687 billion in H1 2025 to 1.672 billion in H1 2026 (a 0.9% reduction). This lower share count mechanically contributed to the 4.9% adjusted diluted EPS growth of $2.80, even as underlying operating income growth was more modest.

What is the execution mechanism for these repurchases?

Altria conducts its share repurchases under Rule 10b-18 open-market purchases, which allows the company to buy shares in the public market subject to volume, timing, and price limitations designed to prevent market manipulation.

Why would Altria continue buybacks amid headwinds in smokeable and oral segments?

Even as domestic cigarette volumes declined 2.8% and oral tobacco volumes fell 6.0% in H1 2026, Altria's strong profitability and cash generation (generating adjusted OCI growth in smokeable products) support capital returns. Buybacks are one lever for returning cash to shareholders; the company also paid $3.6 billion in dividends in H1 2026, reflecting management's confidence in underlying cash flows.

What happens to the remaining authorization after December 31, 2026?

The $2 billion program expires on December 31, 2026. Any undeployed amount ($665 million as of June 30) will be forfeited unless the Board authorizes a new or extended program. Future repurchases depend on board authorization and marketplace conditions, per the company's forward-looking statements.

MO 8-K Filed 2026-07-30 Execution disclosure

Altria repurchased 5.3M shares at $62.78 avg in H1 2026

$335M spent through June 30 under $2B program expiring December 31, 2026; $665M remaining

Shares repurchased5.3M

Avg price paid$62.78

Remaining$665M

MechanismRule 10b-18 open-market purcha

What the filing says

Altria Group, Inc. (NYSE: MO) executed share repurchases totaling $335 million through the first half of 2026, acquiring 5.3 million shares at an average price of $62.78 per share. In the second quarter alone, the company repurchased 0.8 million shares at an average price of $65.11 per share for a total cost of $55 million.

The repurchases are conducted under Altria's $2 billion share repurchase program, which was authorized previously and expires on December 31, 2026. As of June 30, 2026, the company had $665 million remaining under this authorization.

The company disclosed in its earnings press release that it returned nearly $3.9 billion to shareholders in the first half of 2026 through combined dividends and share repurchases. The share count reduction supported adjusted diluted earnings per share growth of 4.9% in the first half, contributing to the company's reported adjusted diluted EPS of $2.80.

In the second quarter, we repurchased 0.8 million shares at an average price of $65.11 per share, for a total cost of $55 million. Through the first half, we repurchased 5.3 million shares at an average price of $62.78 per share, for a total cost of $335 million. As of June 30, 2026, we had $665 million remaining under our $2 billion share repurchase program, which expires on December 31, 2026. — ALTRIA GROUP, INC. 8-K filing · View on SEC EDGAR →

What this means

Altria's H1 2026 share repurchases contributed to per-share earnings accretion at a time when the company faced volume pressures in both smokeable and oral tobacco segments. The $335 million deployed represents roughly 23% of the total $665 million remaining under the program, which expires at year-end 2026. With a weighted-average diluted share count of 1.672 billion at mid-year (down 0.9% year-over-year), the repurchase activity mechanically supported EPS growth despite modest underlying revenue growth of 1.6% for the first six months. The company's execution at an average price of $62.78 per share reflects typical open-market purchase patterns during the period covered by the earnings report.

Frequently asked questions

How much of Altria's $2 billion buyback authorization has been used as of June 30, 2026?: Altria has deployed $335 million of the $2 billion authorization through the first half of 2026, leaving $665 million remaining. The program expires on December 31, 2026. At the current burn rate (approximately $167.5 million per quarter based on H1 results), the remaining funds could support continued repurchases through year-end, though actual execution depends on market conditions and board discretion.
What was the average price paid per share in Q2 2026 versus the first-half average?: In Q2 2026, Altria paid an average of $65.11 per share, compared to the first-half average of $62.78 per share. The higher Q2 price reflects typical seasonal pricing in open-market buybacks and any price appreciation during the second quarter relative to Q1 2026.
How did the share repurchases affect Altria's per-share earnings growth?: The 5.3 million shares repurchased in H1 2026 reduced the weighted-average diluted share count from 1.687 billion in H1 2025 to 1.672 billion in H1 2026 (a 0.9% reduction). This lower share count mechanically contributed to the 4.9% adjusted diluted EPS growth of $2.80, even as underlying operating income growth was more modest.
What is the execution mechanism for these repurchases?: Altria conducts its share repurchases under Rule 10b-18 open-market purchases, which allows the company to buy shares in the public market subject to volume, timing, and price limitations designed to prevent market manipulation.
Why would Altria continue buybacks amid headwinds in smokeable and oral segments?: Even as domestic cigarette volumes declined 2.8% and oral tobacco volumes fell 6.0% in H1 2026, Altria's strong profitability and cash generation (generating adjusted OCI growth in smokeable products) support capital returns. Buybacks are one lever for returning cash to shareholders; the company also paid $3.6 billion in dividends in H1 2026, reflecting management's confidence in underlying cash flows.
What happens to the remaining authorization after December 31, 2026?: The $2 billion program expires on December 31, 2026. Any undeployed amount ($665 million as of June 30) will be forfeited unless the Board authorizes a new or extended program. Future repurchases depend on board authorization and marketplace conditions, per the company's forward-looking statements.

execution altria tobacco rule-10b-18 h1-2026 shareholder-returns

Source. This editorial summary is based on the SEC filing linked above. BuybackStocks aggregates and editorializes publicly available SEC EDGAR filings. Not investment advice. Past authorization announcements do not guarantee future repurchase activity or share price performance. See our full disclosures policy.